News & Analysis on Clinical Trial Services & Contract Research And Development
Millipore has introduced a single-use prefilter for clarification steps in mammalian cell synthesis that continues the trend towards increasing use of disposable technologies in the bioprocessing environment, reports Phil Taylor.
Cardiome Pharma has completed its second Phase I trial for the controlled release oral formulation of RSD1235, an anti-arrhythmic drug candidate that could well provide an effective drug therapy for its 7 million sufferers worldwide.
Exelixis has submitted an investigational new drug application (IND) to the US Food and Drug Administration (FDA) for XL820, a novel small molecule anticancer compound that inhibits receptor tyrosine kinases (RTKs) implicated in tumour proliferation...
Sigma, a division of Sigma-Aldrich Corporation has launched a new offering of Custom AQUA Peptides for use with Protein-AQUA Quantitative Proteomics, enabling important applications as differential protein expression, biomarker quantification and RNAi...
According to a new report, nanotechnology is set to play a major part in drug delivery systems especially for tumour therapies. The report cites nanoparticles as being particularly suited to curing specific conditions such as cancer, as their sizes...
An electronic nebuliser that matches a product formulation, which was specifically developed to optimise this device's performance, marks a new advance in the customisation of drug development and represents a new aerosol delivery platform technology.
Bentley Pharmaceuticals has entered into an agreement with Dong Sung Pharmaceuticals for the development of an intranasal spray formulation of insulin for the South Korean market with the view of extending this deal into additional territories.